https://connections.n1collaborative.org 2026-11-04T23:33:52+00:00 daily 1.0 https://connections.n1collaborative.org/search 2026-11-04T23:33:52+00:00 daily 0.9 https://connections.n1collaborative.org/posts 2026-11-04T23:33:52+00:00 hourly 0.9 https://connections.n1collaborative.org/members 2026-11-04T23:33:52+00:00 hourly 0.9 https://connections.n1collaborative.org/questions 2026-11-04T23:33:52+00:00 hourly 0.9 https://connections.n1collaborative.org/collections/2768427 2026-11-04T23:33:52+00:00 weekly 0.9 https://connections.n1collaborative.org/collections/2779970 2026-11-04T23:33:52+00:00 weekly 0.9 https://connections.n1collaborative.org/collections/2780033 2026-11-04T23:33:52+00:00 weekly 0.9 https://connections.n1collaborative.org/collections/2979765 2026-11-04T23:33:52+00:00 weekly 0.9 https://connections.n1collaborative.org/posts/from-rare-disease-discovery-to-approval-regulatory-strategies-expedited-pathways-and-smarter-evidence-generation-109671368 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-tychobio-long-read-transcriptomic-sequencing 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/n1c-annual-meeting-2026-98883882 2026-11-04T17:54:58+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-aso-control-panel-toxicity-studies 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-customized-promotional-products-97239021 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-rare-rebels%E2%84%A2-podcast-story 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-clinical-trial-management-software 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-scientific-advisory-consultation 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-complimentary-strategic-consultation-for-rare-disease-oligonucleotide-programs-and-discounted-strategic-cmc-advisory-services 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-bioanalytical-services-for-oligonucleotides 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-phosphoramidite-building-blocks-for-oligonucleotide-synthesis 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-oligonucleotide-api 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-raw-materials-for-oligonucleotide-synthesis 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-research-grade-oligonucleotide-manufacturing 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-safety-assessment-services 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-scientific-consultation-97233997 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-screening-oligos 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-scientific-advisory-consultation-oligonucleotide-design 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-aso-design-services 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-scientific-advisory-services 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-genome-sequencing 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-drug-product-manufacturing-sterile-fill-finish 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/navigating-institutional-implementation-a-quarterly-open-forum-for-n-of-1-clinical-trials-108996551 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/institutional-implementation-workgroup 2026-11-04T17:54:45+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/n1c-2026-annual-meeting 2026-11-04T17:55:06+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-pacbio-hifi-whole-genome-sequencing-reagents 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/changing-the-system-to-meet-the-new-era-of-individualized-medicines-105682918 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-consensus-guidelines-for-eligibility-assessment-of-pathogenicvariants-to-antisense-oligonucleotide-treatments-the-n1c-variant-guidelines-20 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/job-description-director-of-revenue 2026-11-04T17:55:03+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/regulatory-workgroup 2026-11-04T17:54:51+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/manufacturing-workgroup 2026-11-04T17:54:44+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/preclinical-design-workgroup 2026-11-04T17:54:42+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/workshops-presentations-allele-selective-therapeutic-strategies-from-design-to-preclinical-testing 2026-11-04T17:54:25+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/the-computational-toolbox-for-individualized-medicine-in-silico-methods-of-antisense-oligonucleotide-design-102209019 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/cmc-roadmap-and-framework-for-n1-oligonucleotide-therapeutics-101156696 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/developing-oligonucleotide-therapeutics-for-rare-indications-an-academic-perspective-101388395 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/our-sponsors 2026-11-04T17:54:16+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-positive-and-negative-controls-for-ssasos-and-gapmers-that-can-be-used-for-in-vitro-tox-studies 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/test 2026-04-23T18:53:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s1-e1-when-is-enough-enough 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s1-e2-finding-the-balance-urgency-rigor-and-uncertainty-in-lead-optimization 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s1-e3-smarter-ways-to-identify-treatment-targets 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s1-e4-behind-the-publication-author-insights-on-how-to-pay-for-individualized-genetic-medicines 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s1-e5-molecules-and-methods-reevaluating-aso-biodistribution-to-the-brain 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s1-e6-visionary-science-charting-a-path-for-mutation-based-retinal-interventions 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s2-e1-beyond-the-data-author-insights-on-n-of-1-trials-in-precision-medicine 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s2-e2-scaling-n-of-1-therapies-from-one-to-many 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s2-e3-it-takes-a-village 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s2-e4-the-weight-of-the-unknown 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s2-e5-inside-the-thorny-trench 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-s2-e6-barriers-beyond-biology 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/navigating-institutional-implementation-a-quarterly-open-forum-for-n-of-1-clinical-trials-98865046 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/regulatory-guidance-considerations-for-the-use-of-the-plausible-mechanism-framework-to-develop-individualized-therapies-that-target-specific-genetic-conditions-with-known-biological-cause 2026-11-04T17:54:34+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/beyond-compassionate-use-building-a-master-protocol-to-advance-development-of-individualized-medicines-at-scale 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-interventional-genomics-bridging-germline-diagnosis-and-therapeutic-action-98253817 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-communications-community-support 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-preclinical-development-safety 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-therapeutic-design-optimization 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-clinical-regulatory-enablement 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-manufacturing 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-discovery-early-research 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-overview-97228772 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-delete-97228771 2026-11-04T17:54:54+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-response-to-the-fdas-proposed-pathwayfor-individualized-genetic-therapies 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/access-funding-workgroup 2026-11-04T17:54:49+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/clinical-outcomes-workgroup 2026-11-04T17:54:47+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/patient-identification-workgroup 2026-11-04T17:54:41+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/regulatory-guidance-scge-shared-regulatory-documents 2026-11-04T17:54:34+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-how-a-tailored-als-drug-could-help-broaden-rare-disease-therapies 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-treatment-of-a-teenager-with-an-ultra-rare-condition-is-a-medical-milestone 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/regulatory-guidance-clinical-recommendations-draft-guidance 2026-11-04T17:54:34+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-screening-rare-genetic-diagnoses-for-amenability-to-bespoke-antisense-oligonucleotide-therapy-development-a-retrospective-cohort-study 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-how-to-create-personalized-gene-editing-platforms-next-steps-toward-interventional-genetics 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-from-roadmap-to-a-sustainable-end-to-end-individualized-therapy-pathway 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/nih-support-for-the-development-of-therapeutic-platform-approaches-to-treat-monogenic-disease-94490696 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/deciphering-sptan1-associated-disease-mechanism-and-potential-therapy-in-patient-derived-cell-lines 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/cmc-aspects-of-individualized-platforms 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/preclinical-development-of-personalized-aso-therapeutics-using-patient-derived-organoid-systems-89836700 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/data-coordination-workgroup 2026-11-04T17:54:48+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/n-of-small-trial-with-lbsl 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/n1c-variant-guidelines-tools 2026-11-04T17:54:39+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/workshops-presentations-bold-predictions-for-human-genomics-by-2030-session-10 2026-11-04T17:54:25+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/workshops-presentations-rare-x-exchange-the-future-is-now-realizing-the-possibilities-of-patient-driven-research 2026-11-04T17:54:25+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/workshops-presentations-discovery-forum-2022-julia-vitarello-timothy-yu-from-mila-to-millions 2026-11-04T17:54:25+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/regulatory-guidance-administrative-and-procedural-draft-guidance 2026-11-04T17:54:34+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/regulatory-guidance-nonclinical-testing-draft-guidance 2026-11-04T17:54:34+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/regulatory-guidance-cmc-recommendations-draft-guidance 2026-11-04T17:54:34+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-drug-regulation-in-the-era-of-individualized-therapies 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-making-genetic-therapies-affordable-and-accessible 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-all-of-us-and-the-promise-of-precision-medicine 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-this-is-not-a-science-problem-anymore-paths-emerge-for-scaling-up-rare-disease-disease 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-a-multistakeholder-perspective-on-advancing-individualized-therapeutics 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-how-to-pay-for-individualized-genetic-medicines 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-employers-dont-want-to-pay-for-life-saving-cures-for-rare-diseases 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-joining-forces-to-develop-individualized-antisense-oligonucleotides-for-patients-with-brain-or-eye-diseases-the-example-of-the-dutch-center-for-rna-therapeutics 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-personalized-medicine-for-rare-neurogenetic-disorders-can-we-make-it-happen 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-the-rare-therapies-launchpad-a-pilot-program-for-individualized-medicines-in-the-uk 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/models-for-sustainable-discovery 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/new-business-models-and-funding-strategies-for-developing-and-paying-for-rare-diseases 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/from-mutation-to-dose-able-crispr-medicine-in-3-months-obstacles-actionable-paths-forward 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/regulatory-pathway-where-we-are-today 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/regulatory-the-future-pathway-to-access 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/stopping-the-clock-on-kif1a-associated-neurological-disorder 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/transforming-patient-access-to-high-cost-one-time-treatments-through-financial-engineering-innovation 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/the-challenges-and-opportunities-in-rare-disease-89825266 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/treating-the-nano-rare-redefining-clinical-management-one-patient-at-a-time 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/data-sharing-an-open-letter 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/workshops-presentations-year-end-review-and-outcome-measures-workshop 2026-11-04T17:54:25+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-patient-customized-oligonucleotide-therapy-for-a-rare-genetic-disease 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-n-of-1-studies-in-an-era-of-precision-medicine 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-a-framework-for-n-of-1-trials-of-individualized-gene-targeted-therapies-for-genetic-diseases 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-suppression-of-mutant-c9orf72-expression-by-a-potent-mixed-backbone-antisense-oligonucleotide 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/rapid-development-of-an-n-of-few-gene-therapy-for-spg50-through-duantless-collaboration 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/an-overview-of-the-n1-collaborative-and-aso-treatment-for-kcnt1 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/perspectives-on-clinical-outcomes-for-n1-patients-insights-from-n1c-clinical-outcomes-workgroup 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/potential-treatment-cmt2s-caused-by-ighmbp2-cryptic-splice-site-variant-with-aso-based-therapeutic 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/prax-222-therapy-for-a-child-prenatal-onset-scn2a-developmental-and-epileptic-encephalopathy-in-a-named-patient-setting 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/project-butterfly-from-drug-development-to-clinical-trial-a-personalized-antisense-oligonucleotide-medicine-for-a-rare-form-of-cln3-batten-disease 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/personalized-splice-modulating-antisense-oligonucleotide-therapy-for-pex1-related-zellweger-spectrum-disorder 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/towards-a-divalent-sirna-therapy-for-prion-disease-an-academic-patient-scientist-led-effort-89836215 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/splice-altering-transposon-insertions-in-neurodegenerative-diseases-and-its-application-in-an-individualized-aso-therapy-for-retinitis-pigmentosa-89816404 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/workshops-presentations-institutional-implementation-workshop 2026-11-04T17:54:25+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-illustrated-example-for-n1-clinical-protocol 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/approach-to-drafting-regulatory-submissions-and-challenges-of-institutional-implementation 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/control-of-starting-material-quality-for-oligonucleotide-therapeutics-and-to-synthesis-and-beyond%E2%80%A6production-of-oligos-for-n-of-1-therapies 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/fast-track-to-final-drug-product-understanding-costs-challenges-and-timelines-in-personalized-medicine-manufacturing 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/rnadna-based-analytics-to-guarantee-product-safety-challenges-for-n-of-1-treatments 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-cmc-recommendations-draft-guidance-92002821 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-illustrated-example-for-n1-consent-form 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/workshops-presentations-preclinical-design-of-individualized-antisense-oligonucleotides 2026-11-04T17:54:25+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-nonclinical-testing-draft-guidance-92002830 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-consensus-guidelines-for-the-design-and-in-vitro-preclinical-efficacy-testing-n1-exon-skipping-asos 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-strategies-to-improve-the-design-of-gapmer-antisense-oligonucleotide-on-allele-specific-silencing 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-a-guide-to-chemical-considerations-for-the-pre-clinical-development-of-oligonucleotides 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-n1c-preclinical-workgroup-valuable-tools-for-the-preclinical-stage-of-developing-potential-therapeutics 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-n1c-preclinical-workgroup-ordering-aso-checklist 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-n1c-preclinical-workgroup-preclinical-modeling-systems 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/the-most-important-aspects-of-the-guidelines-for-n1-exon-skipping-design-and-in-vitro-development 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/preclinical-development-for-personalized-therapy-using-disease-relevant-cell-models 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/snp-selective-sirna-for-the-treatment-of-fibrodysplasia-ossificans-progressiva 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/podcasts-podcast-overview 2026-11-04T17:54:37+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/n1c-gene-registry 2026-11-04T17:54:36+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/regulatory-guidance-overview 2026-11-04T17:54:34+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/newsletters-happy-holidays-a-call-for-speakers-and-participants-in-2023 2026-11-04T17:54:32+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/newsletters-new-n1c-seminar-series 2026-11-04T17:54:32+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/newsletters-hanging-our-hat-on-shared-learnings 2026-11-04T17:54:32+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/newsletters-sharing-papers-presentations-and-more 2026-11-04T17:54:32+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/newsletters-august-newsletter 2026-11-04T17:54:32+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/newsletters-july-2025-newsletter 2026-11-04T17:54:32+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/newsletters-overview 2026-11-04T17:54:32+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-the-cost-of-delayed-diagnosis-in-rare-disease-a-health-economic-study 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-community-job-openings 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-administrative-and-procedural-draft-guidance-92002826 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-this-is-not-a-science-problem-anymore-paths-emerge-for-scaling-up-rare-disease-medicine 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-community-events 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-n1c-patient-identification-workgroup-compilation-of-useful-tools 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-clinical-recommendations-draft-guidance-92002811 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/illustrated-examples-overview 2026-11-04T17:54:31+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-if-dna-is-like-software-can-we-just-fix-the-code 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-personalized-medicine-is-having-its-day 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-qa-fdas-peter-marks-ready-to-encourage-more-accelerated-approvals-for-rare-diseases 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-the-worlds-first-pathway-for-individually-designed-drugs 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-four-keys-to-advancing-antisense-oligonucleotides-for-personalized-medicine 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-unc-fast-tracks-personalized-treatment-for-twins-with-ultra-rare-genetic-disorder 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-drug-tailored-to-one-girl-with-brain-disease-paves-way-for-similar-customized-treatments 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-hopes-for-antisense-oligonucleotides-remain-strong-despite-severe-adverse-events-in-trials 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-rare-disease-researchers-pioneer-a-unique-approach-to-clinical-trials 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-individualised-medicines-offer-hope-for-children-with-a-rare-disease 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-oxford-harrington-rare-disease-centre-named-first-global-initiative-for-children-with-rare-disease 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-accelerated-approval-will-be-the-norm-for-gene-therapies-fdas-peter-marks-says 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-n1-collaborative-welcomes-hugh-hempel-as-executive-director-to-lead-the-next-phase-of-growth 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-after-a-bespoke-therapy-rescues-a-young-girl-the-fda-considers-advance-of-individualized-treatments 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-a-mother-shaped-by-tragedy-embarks-on-a-mission-to-advance-custom-medicines 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-they-created-a-drug-for-susannah-what-about-millions-of-other-patients 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-a-young-girls-custom-gene-therapy-hints-at-a-framework-for-tailored-rare-disease-treatments 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-early-rare-disease-diagnosis-could-save-as-much-as-500000-per-patient 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-building-a-bridge-between-rare-disease-patients-and-the-technologies-that-could-help-them 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-find-a-way-or-make-one-how-two-scientists-hope-to-revitalize-crisprs-rare-disease-crisis 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-when-right-to-try-isnt-enough-congress-wants-a-single-als-patient-to-get-a-therapy-never-tested 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-from-mila-to-millions 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-democratizing-drug-development-will-be-a-win-for-all 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-the-quest-for-the-era-of-personalised-medicine 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-this-lifesaving-treatment-was-designed-for-one-could-it-be-the-future-of-medical-care 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-a-baby-receives-the-first-customized-crispr-treatment 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-this-girls-dramatic-story-shows-hyper-personalized-medicine-is-possible-and-costly 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-individualized-aso-therapy-for-rare-diseases 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-gene-treatment-for-rare-epilepsy-causes-brain-side-effect-in-2-children 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-too-many-treatable-diseases-go-unnoticed-this-could-change-that 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-what-we-owe-terry-horgan-reflections-from-providers-family-and-scientists 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-pilot-launched-to-support-children-with-rare-conditions-to-access-personalised-therapies 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-the-new-era-of-individualized-medicine-requires-a-genetic-surgery-system 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-we-can-cure-disease-by-editing-a-persons-dna-why-arent-we 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-n-of-1-therapies-how-clinical-trials-for-a-single-patient-can-change-the-future 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-collaboratives-companies-mobilize-to-buildmomentum-for-n-of-1-aso-therapies 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-can-ai-build-custom-n-of-1-drugs-faster-maybe-not-yet-new-case-study-suggests 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/articles-overview 2026-11-04T17:54:29+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-ots-rare-disease-n-of-1-briefing-document-jan-2020 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-antisense-oligonucleotide-silencing-of-fus-expression-as-a-therapeutic-approach-in-amyotrophic-later 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-consensus-guidelines-for-the-design-and-in-vitro-preclinical-efficacy-testing-n-of-1 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-new-antisense-oligonucleotide-therapies-reach-first-base-in-als 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-possibilities-and-limitations-of-antisense-oligonucleotide-therapies-for-the-treatment-of-monogenic-disorders 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-a-framework-for-individualized-splice-switching-oligonucleotide-therapy 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-practical-recommendations-for-the-selection-of-patients-for-individualized-splice-switching-aso-based-treatments 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-the-state-of-the-art-of-n-of-1-therapies-and-the-irdirc-n-of-1-development-roadmap 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-consensus-guidelines-for-assessing-eligibility-of-pathogenic-dna-variants-for-antisense-oligonucleotide-treatments 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-the-n1-collaborative-advancing-customized-nucleic-acid-therapies-through-collaboration-and-data-sharing 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-patient-specific-in-vivo-gene-editing-to-treat-a-rare-genetic-disease 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/publications-overview-92002234 2026-11-04T17:54:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/advancing-human-hematopoietic-stem-cell-therapies-from-sickle-cell-disease-to-personalized-treatments-for-bone-marrow-failure-disorders-89836641 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/workshops-presentations-n1-collaborative-introduction-patient-selection-workshop 2026-11-04T17:54:25+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/workshops-presentations-n1c-variant-workshop 2026-11-04T17:54:25+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/workshops-presentations-navigating-institutional-implementation-a-quarterly-open-forum-for-n-of-1-clinical-trials 2026-11-04T17:54:25+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/workshops-presentations-overview 2026-11-04T17:54:25+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/tailored-rna-therapies-for-ultrarare-cns-diseases-mutations-a-criteria-framework-for-patient-id 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/selecting-the-right-candidate-which-disease-causing-variants-are-eligible-for-n1-asos 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/connecting-collaborating-communicating-challenges-sharing-experiences-navigating-family-conversations-in-an-n-of-1-investigational-treatment-setting 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/towards-a-platform-for-in-vivo-corrective-editing-of-ultra-rare-and-n-of-1-metabolic-disorders 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/draft-template 2025-10-10T01:10:13+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/navigating-institutional-implementation-a-quarterly-open-forum-for-n-of-1-clinical-trials 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-safety-assessment-services-charles-river-laboratories 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/phage-therapy-for-multidrug-resistant-bacterial-infections-past-and-future 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/snakeholders-and-stakeholders-how-zookeepers-and-border-smugglers-set-the-stage-for-antivenom-commercialization-in-the-usa 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/patient-partners-harnessing-synergies-to-pursue-asos-as-part-of-the-ahc-research-portfolio 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/parents-of-pioneers-real-experiences-in-individualized-medicines-today 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/what-if-coding-personalized-aso-therapies-only-required-the-press-of-a-button 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/aso-treatment-for-scn2a-encephalopathy-allele-specific-vs-non-specific 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/advancing-human-hematopoietic-stem-cell-therapies-from-sickle-cell-disease-to-personalized-treatments-for-bone-marrow-failure-disorders-89836634 2025-10-17T16:38:35+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/the-challenges-and-opportunities-in-rare-disease 2025-08-27T13:04:27+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/seminar-series-preclinical-development-of-personalized-aso-therapeutics-using-patient-derived-organoid-systems 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/seminar-series-advancing-human-hematopoietic-stem-cell-therapies-from-sickle-cell-disease-to-personalized-treatments-for-bone-marrow-failure-disorders 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/seminar-series-towards-a-divalent-sirna-therapy-for-prion-disease-an-academic-patient-scientist-led-effort 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/seminar-series-splice-altering-transposon-insertions-in-neurodegenerative-diseases-and-its-application-in-an-individualized-aso-therapy-for-retinitis-pigmentosa 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-aso-control-panel-toxicity-studies-oligo-factory 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-overview 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-bold-predictions-for-human-genomics-by-2030-session-10 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-rare-x-exchange-the-future-is-now-realizing-the-possibilities-of-patient-driven-research 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-discovery-forum-2022-julia-vitarello-timothy-yu-from-mila-to-millions 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-administrative-and-procedural-draft-guidance-89611113 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-nonclinical-testing-draft-guidance-89611082 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-cmc-recommendations-draft-guidance-89611047 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-clinical-recommendations-draft-guidance-89611021 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-drug-regulation-in-the-era-of-individualized-therapies 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-making-genetic-therapies-affordable-and-accessible 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-all-of-us-and-the-promise-of-precision-medicine 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-a-multistakeholder-perspective-on-advancing-individualized-therapeutics-89610943 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-this-is-not-a-science-problem-anymore-paths-emerge-for-scaling-up-rare-disease-medicine 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-how-to-pay-for-individualized-genetic-medicines 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-employers-dont-want-to-pay-for-life-saving-cures-for-rare-diseases 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-joining-forces-to-develop-individualized-antisense-oligonucleotides-for-patients-with-brain-or-eye-diseases-the-example-of-the-dutch-center-for-rna-therapeutics 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-personalized-medicine-for-rare-neurogenetic-disorders-can-we-make-it-happen 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-the-rare-therapies-launchpad-a-pilot-program-for-individualized-medicines-in-the-uk 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-from-roadmap-to-a-sustainable-end-to-end-individulized-therapy-pathway 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-how-a-tailored-als-drug-could-help-broaden-rare-disease-therapies 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-models-for-sustainable-discovery-89609304 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-new-business-models-and-funding-strategies-for-developing-and-paying-for-rare-diseases 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-regulatory-pathway-where-we-are-today-89608751 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-models-for-sustainable-discovery 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-from-mutation-to-dose-able-crispr-medicine-in-3-months-obstacles-actionable-paths-forward 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-regulatory-the-future-pathway-to-access 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-stopping-the-clock-on-kif1a-associated-neurological-disorder-89608583 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-transforming-patient-access-to-high-cost-one-time-treatments-through-financial-engineering-innovation 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-the-challenges-and-opportunities-in-rare-disease 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-treating-the-nano-rare-redefining-clinical-management-one-patient-at-a-time-89600110 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-personalized-splice-modulating-antisense-oligonucleotide-therapy-for-pex1-related-zellweger-spectrum-disorder-89594251 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-towards-a-platform-for-in-vivo-corrective-editing-of-ultra-rare-and-n-of-1-metabolic-disorders-89594250 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-splice-altering-transposon-insertions-in-neurodegenerative-diseases-and-its-application-in-an-individualized-aso-therapy-for-retinitis-pigmentosa-89594110 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-patient-customized-oligonucleotide-therapy-for-a-rare-genetic-disease 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-year-end-review-and-outcome-measures-workshop 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-a-multistakeholder-perspective-on-advancing-individualized-therapeutics-89599704 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-n-of-1-studies-in-an-era-of-precision-medicine 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-n1c-preclinical-workgroup-valuable-tools-for-the-preclinical-stage-of-developing-potential-therapeutics 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-n1c-preclinical-workgroup-ordering-aso-checklist 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-n1c-preclinical-workgroup-preclinical-modeling-systems 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-nonclinical-testing-draft-guidance 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-cmc-recommendations-draft-guidance 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-clinical-recommendations-draft-guidance 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-administrative-and-procedural-draft-guidance 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-a-framework-for-n-of-1-trials-of-individualized-gene-targeted-therapies-for-genetic-diseases 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-suppression-of-mutant-c9orf72-expression-by-a-potent-mixed-backbone-antisense-oligonucleotide 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-an-overview-of-the-n1-collaborative-and-aso-treatment-for-kcnt1 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-n-of-small-trial-with-lbsl 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-perspectives-on-clinical-outcomes-for-n1-patients-insights-from-n1c-clinical-outcomes-workgroup 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-aso-treatment-for-scn2a-encephalopathy-allele-specific-vs-non-specific 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-potential-treatment-cmt2s-caused-by-ighmbp2-cryptic-splice-site-variant-with-aso-based-therapeutic 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-project-butterfly-from-drug-development-to-clinical-trial-a-personalized-antisense-oligonucleotide-medicine-for-a-rare-form-of-cln3-batten-disease 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-prax-222-therapy-for-a-child-prenatal-onset-scn2a-developmental-and-epileptic-encephalopathy-in-a-named-patient-setting 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-stopping-the-clock-on-kif1a-associated-neurological-disorder 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-rapid-development-of-an-n-of-few-gene-therapy-for-spg50-through-duantless-collaboration 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-treating-the-nano-rare-redefining-clinical-management-one-patient-at-a-time 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-data-sharing-an-open-letter 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-illustrated-example-for-n1-consent-form 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-n1-collaborative-introduction-patient-selection-workshop 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-research-grade-oligonucleotide-manufacturing-biospring-gmbh 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-bioanalytical-services-for-oligonucleotides-biospring-gmbh 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-screening-oligos-microsynth 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-clinical-trial-management-software-jeeva 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-raw-materials-for-oligonucleotide-synthesis-hongene-88329478 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-oligonucleotide-api-chemgenes 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-phosphoramidite-building-blocks-for-oligonucleotide-synthesis-chemgenes-88329218 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-aso-design-services-charles-river-laboratories 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-scientific-advisory-services-charles-river-laboratories 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-scientific-advisory-services-advirna 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-scientific-advisory-consultation-n-of-1-hub 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-scientific-consultation-ixcells-biotechnologies 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-customized-promotional-products-u-spark-branding 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-drug-product-manufacturing-sterile-fill-finish-argonaut-88329003 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-genome-sequencing-3billion 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-institutional-implementation-workshop 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-illustrated-example-for-n1-clinical-protocol 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-approach-to-drafting-regulatory-submissions-and-challenges-of-institutional-implementation 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-regulatory-pathway-where-we-are-today 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-control-of-starting-material-quality-for-oligonucleotide-therapeutics-and-to-synthesis-and-beyond%E2%80%A6production-of-oligos-for-n-of-1-therapies 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-fast-track-to-final-drug-product-understanding-costs-challenges-and-timelines-in-personalized-medicine-manufacturing 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-rnadna-based-analytics-to-guarantee-product-safety-challenges-for-n-of-1-treatments 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-workshop-preclinical-design-of-individualized-antisense-oligonucleotides 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-consensus-guidelines-for-the-design-and-in-vitro-preclinical-efficacy-testing-n1-exon-skipping-asos 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-strategies-to-improve-the-design-of-gapmer-antisense-oligonucleotide-on-allele-specific-silencing 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-a-guide-to-chemical-considerations-for-the-pre-clinical-development-of-oligonucleotides 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-positive-and-negative-controls-for-ssasos-and-gapmers-that-can-be-used-for-in-vitro-tox-studies 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-the-most-important-aspects-of-the-guidelines-for-n1-exon-skipping-design-and-in-vitro-development 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-preclinical-development-for-personalized-therapy-using-disease-relevant-cell-models 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-snp-selective-sirna-for-the-treatment-of-fibrodysplasia-ossificans-progressiva 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-personalized-splice-modulating-antisense-oligonucleotide-therapy-for-pex1-related-zellweger-spectrum-disorder 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-towards-a-platform-for-in-vivo-corrective-editing-of-ultra-rare-and-n-of-1-metabolic-disorders-89005592 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-the-cost-of-delayed-diagnosis-in-rare-disease-a-health-economic-study 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-ots-rare-disease-n-of-1-briefing-document-jan-2020 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-a-framework-for-individualized-splice-switching-oligonucleotide-therapy 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-a-multistakeholder-perspective-on-advancing-individualized-therapeutics 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-publication-possibilities-and-limitations-of-antisense-oligonucleotide-therapies-for-the-treatment-of-monogenic-disorders 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-publication-practical-recommendations-for-the-selection-of-patients-for-individualized-splice-switching-aso-based-treatments 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-n1c-variant-guidelines-and-tools 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-publication-consensus-guidelines-for-assessing-eligibility-of-pathogenic-dna-variants-for-antisense-oligonucleotide-treatments 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-n1c-gene-registry 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-tailored-rna-therapies-for-ultrarare-cns-diseases-mutations-a-criteria-framework-for-patient-id 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-selecting-the-right-candidate-which-disease-causing-variants-are-eligible-for-n1-asos 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-connecting-collaborating-communicating-challenges-sharing-experiences-navigating-family-conversations-in-an-n-of-1-investigational-treatment-setting 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/seminar-series-overview 2026-11-04T17:54:21+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-access-funding 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-data-coordination 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-clinical-outcomes 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-institutional-implementation 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-manufacturing 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-patient-identification 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-n1c-variant-workshop 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-splice-altering-transposon-insertions-in-neurodegenerative-diseases-and-its-application-in-an-individualized-aso-therapy-for-retinitis-pigmentosa 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-towards-a-platform-for-in-vivo-corrective-editing-of-ultra-rare-and-n-of-1-metabolic-disorders 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/resource-navigator-preclinical-design 2026-11-04T17:54:20+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-overview-87736001 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-delete 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/donated-resource-center-directory-of-donated-resources 2026-11-04T17:54:19+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/84910185 2026-11-04T17:54:07+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/access-funding-overview 2026-11-04T17:54:06+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/data-coordination-overview 2026-11-04T17:54:06+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/clinical-outcomes-overview 2026-11-04T17:54:06+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/institutional-implementation-overview 2026-11-04T17:54:06+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/manufacturing-overview 2026-11-04T17:54:06+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/preclinical-design-overview 2026-11-04T17:54:06+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/patient-identification-workshops 2026-11-04T17:54:05+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/patient-identification-publications 2026-11-04T17:54:05+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/patient-identification-workgroup-generated-content 2026-11-04T17:54:05+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/patient-identification-seminars-podcasts 2026-11-04T17:54:05+00:00 weekly 0.5 https://connections.n1collaborative.org/posts/patient-identification-overview 2026-11-04T17:54:05+00:00 weekly 0.5